Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 4Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 14Colonic Neoplasms 10Rectal Neoplasms 9Pancreatic Neoplasms 8Cholangiocarcinoma 7Neoplasm Metastasis 6Carcinoma, Hepatocellular 6Vomiting 5Stomach Neoplasms 4Nausea 4Liver Neoplasms 4Esophageal Neoplasms 4Bile Duct Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Seminoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pain, Postoperative 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mesothelioma 1Malnutrition 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 12Nivolumab 6Cyclophosphamide 6fludarabine 5Ipilimumab 4amatuximab 3Cisplatin 3tislelizumab 2spartalizumab 2fludarabine phosphate 2budigalimab 2belinostat 2Plicamycin 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorouracil 2Cytoreduction Surgical Procedures 2venetoclax 1tocilizumab 1talazoparib 1sotorasib 1rovalpituzumab tesirine 1obinutuzumab 1niraparib 1naptumomab estafenatox 1milademetan 1irinotecan sucrosofate 1epacadostat 1enzalutamide 1durvalumab 1defactinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma × Dexamethasone × Gastrointestinal × Clear all
NCT05070247 2026-01-22

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Takeda

Phase 1/2 Terminated
61 enrolled 29 charts
BreastGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Mesothelioma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡